HBV News and Research

RSS
Roche's new dual-target HIV-1 test approved in Europe

Roche's new dual-target HIV-1 test approved in Europe

Does HBV infection induce acute cellular DNA damage?

Does HBV infection induce acute cellular DNA damage?

FDA approves DNA test to measure hepatitis B viral load

FDA approves DNA test to measure hepatitis B viral load

Hunt for baby denied HBV shot

Hunt for baby denied HBV shot

Viread approved for chronic hepatitis B

Viread approved for chronic hepatitis B

EpiCept and GNI partner to develop anti-viral hepatitis drug in Asia

EpiCept and GNI partner to develop anti-viral hepatitis drug in Asia

Hepatitis B virus triggers cell 'suicide' in patients with chronic infection

Hepatitis B virus triggers cell 'suicide' in patients with chronic infection

BARACLUDE data show low resistance over 5 years in nucleoside-naive hepatitis B patients

BARACLUDE data show low resistance over 5 years in nucleoside-naive hepatitis B patients

Abbott receives approval for HUMIRA (Adalimumab) for polyarticular juvenile idiopathic arthritis

Abbott receives approval for HUMIRA (Adalimumab) for polyarticular juvenile idiopathic arthritis

Low prevalence of Helicobacter pylori in HIV-positive patients

Low prevalence of Helicobacter pylori in HIV-positive patients

FDA fast tracks PI-88 for the treatment of post resection liver cancer

FDA fast tracks PI-88 for the treatment of post resection liver cancer

Liver cancer marker could yield blood test for early detection

Liver cancer marker could yield blood test for early detection

Research looks at hepatitis C recovery

Research looks at hepatitis C recovery

Protecting HIV patients from Hep B

Protecting HIV patients from Hep B

Many needle-stick injuries unreported

Many needle-stick injuries unreported

When HIV and liver disease co-exist

When HIV and liver disease co-exist

Liver cancer patients with high serum levels of hepatitis B virus face poorer outcomes

Liver cancer patients with high serum levels of hepatitis B virus face poorer outcomes

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Bristol-Myers Squibb announces new results of Baraclude (entecavir) resistance monitoring program

Bristol-Myers Squibb announces new results of Baraclude (entecavir) resistance monitoring program